Grants for Unrestricted - Federal

This grant seeks to foster collaboration among private sector, civil society, and academia in Bosnia and Herzegovina to accelerate digital transformation and development in the country.

The purpose of this Amendment is to provide answers to the questions submitted by the interested applicants, and to provide specific changes that were made to the original RFA . All changes in the amended RFA are highlighted for ease of reference.Thank you for your interest in USAID programs.

This opportunity seeks input from organizations in the Caribbean with proven experience in multi-country development initiatives to enhance regional innovation and locally-led partnerships across various sectors.

This grant provides funding for collaborative research teams to advance the understanding and treatment of eye injuries and visual dysfunction caused by military-related exposures.

This funding opportunity provides financial support to local organizations in El Salvador, Guatemala, and Honduras to lead initiatives that promote economic growth, education, citizen security, and governance, prioritizing community-driven solutions and inclusivity.

This grant provides funding to organizations working in Ecuador to promote sustainable land use practices that reduce greenhouse gas emissions and support local livelihoods in areas affected by deforestation and land degradation.

This is a Notice of Funding Opportunity (NOFO) full package to solicit applications for one cooperative agreement from qualified entities to implement the Integrated Health Systems Strengthening (IHSS). Eligibility for this award is not restricted. The purpose of the Integrated Health System Strengthening (IHSS) program is to accelerate countries Health System Strengthening (HSS) efforts and achieve sustainable, equitable, and resilient health systems through locally-led, evidence-driven, and context-specific approaches to HSS. The primary goals are to advance primary health care (PHC), accelerate progress toward universal health coverage (UHC), and improve health outcomes. Investments in HSS help USAID reach its priority global health goals of preventing child and maternal deaths, controlling the HIV/AIDS epidemic, and combating infectious disease, which directly contributes to strengthening global health security. A strengthened and accessible health system is necessary to yield high-quality health services, which are essential for achieving sustainable improvements in health, promoting economic growth, and overall democratic development.Please find the entire full announcement in the "Related Documents" tab.Issue Date: May 07, 2024Q Due Date: May 21, 2024Closing Date: July 06, 2024Closing Time: 11:59 PM EST (Washington, DC)Amendment 1 with questions/answers has been added: May 31, 2024

The United States Agency for International Development (USAID) is seeking applications for a cooperative agreement from qualified entities to implement the Ftifye Manje pou Ranfse Sante ("Strengthening Food to Boost Health#210;TIFYE). Eligibility for this award is not restricted. USAID intends to make an award to the applicant who best meets the objectives of this funding opportunity based on the merit review criteria described in this NOFO subject to a risk assessment. Eligible parties interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements and selection process.To be eligible for award, the applicant must provide all information as required in this NOFO and meet eligibility standards in Section C of this NOFO. This funding opportunity is posted on www.grants.gov, and may be amended. It is the responsibility of the applicant to regularly check the website to ensure they have the latest information pertaining to this notice of funding opportunity and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion process. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at [email protected] for technical assistance.USAID may not award to an applicant unless the applicant has complied with all applicable Unique Entity identifier and System for Award Management (SAM) requirements detailed in Section D.6.g. The registration process may take many weeks to complete. Therefore, applicants are encouraged to begin registration early in the process.Please send any questions to the point(s) of contact identified in Section G. The deadline for questions is shown above. Responses to questions received prior to the deadline will be furnished to all potential applicants through an amendment to this notice posted to www.grants.gov.Issuance of this notice of funding opportunity does not constitute an award commitment on the part of the Government nor does it commit the Government to pay for any costs incurred in preparation or submission of comments/suggestions or an application. Applications are submitted at the risk of the applicants. All preparation and submission costs are at the applicants expense.Thank you for your interest in USAID programs.

The five-year USAID National Family Planning and Adolescent Reproductive Health (FP/ARH) Activity (2024-2029) aims to improve family planning and adolescent reproductive health in the Philippines. It is a key component of the USAID Universal Health Care Project (UHCP) with the goal of improving health outcomes of underserved Filipinos. The FP/ARH Activity will help advance the Philippine governments efforts under the Universal Health Care law to improve the delivery of quality preventive, promotive care at the primary health care level. The Activity will contribute to achieving the Philippine governments health goals as follows: Increase the demand satisfied with modern FP methods among all women of reproductive age from 42 percent in 2022 to 75 percent by 2030; Reduce the adolescent birth rate from 25 per 1,000 girls (age 15-19) in 2022 to 12 per 1,000 girls by 2030; and Reduce the maternal mortality ratio from 144 per 100,000 live births in 2020 to less than 70 per 100,000 live births by 2030

Through the new Civil Society Activity in the Kyrgyz Republic, USAID/Kyrgyz Republic will support Kyrgyz civil society to build stronger relationships with their constituencies, enhance their resilience in the face of democratic backsliding, strengthen trust-based relationships and networks among diverse civic actors, andgenerate support for promotion of democratic values through value-based messaging.

This funding opportunity is designed to support organizations working to improve health services and outcomes for underserved and vulnerable populations in the Philippines, focusing on areas like tuberculosis, family planning, and HIV/AIDS.

The PWSA supports innovative research studies to advance research in preservation of function (physical ability), quality of life, symptom management, resilience, relief from neurocognitive deficits, and support for psychosocial issues related to cancer diagnosis, treatment, and survivorship. Studies must address one or more of these critical issues in at least one of the FY24 PRCRP Topic Areas. The overall intention of the PWSA is to fill gaps in the understanding of survivorship, including investigations into the psychological health and well-being of those affected by cancer (e.g., patients, family members). This may include investigations into studies that improve mental health and/or cancer-related outcomes in defined populations. Studies also may assess the relationship(s) between behavioral and social functioning in relation to cancer initiation, progression, detection, treatment, and rehabilitation. Applications may propose studies that examine preservation of function, quality-of-life, well-being, decision-making, and/or cognitive function, development and testing of educational interventions, and symptom management (e.g., toxicity of treatment, palliative/supportive care, psychological distress and anxiety) throughout treatment and beyond. Applications may target development of evidence-based practices, behavioral health science and patient well-being interventions and surveillance, and identification of psychosocial patient outcomes. Basic laboratory studies are not appropriate for the PWSA and may be withdrawn. The critical components of this award mechanism are: Impact: The PWSA is intended to support research that demonstrates the potential to have a major impact on patient well-being, outcomes, and health, including diagnosis, treatment, and after treatment. The proposed study must demonstrate how the research will transform outcomes related to at least one of the FY24 PRCRP Topic Areas. Research should challenge paradigms with respect to impact on patient care and outcomes. Proposed projects may include translational or clinical research, including pilot clinical trials. Impactful research will accelerate the movement of promising ideas into clinical applications and advance quality of life and survivorship. Study Design: Applications should clearly articulate the chosen design of the study. Studies entailing retrospective or prospective recruitment should define the type of architecture of the study (e.g., interventional, descriptive, correlational, field experimental, meta-analyses). Study populations should be clearly defined. The rationale should support the chosen study design with statistical evaluation to back the design. Questionnaires should be described in sufficient detail to justify interpretation of potential results. Studies utilizing animal models are not supported by this funding opportunity and may be withdrawn. Preliminary Data: The PWSA will require preliminary data for all studies that propose the active (prospective) recruitment of human subjects for pilot clinical trials. Studies not proposing active recruitment of human subjects are not required to present preliminary data but should be supported by sound reasoning and relevant literature. Patient Advocate Participation: Applications to the PWSA funding opportunity are required to include patient advocates. The research team must include at least one cancer patient advocate who will be integral throughout the planning and implementation of the research project. The patient advocate should be active in a cancer advocacy organization, have a high level of knowledge of current cancer issues, and be a representative from the FY24 PRCRP Topic Area(s) that is being studied. The patient advocate will be a person living with cancer; a person previously diagnosed with/treated for cancer but who now has no evidence of disease; or a family member or caretaker of someone with cancer. The patient advocate should be involved in the development of the research question, project design, oversight, and evaluation, as well as other significant aspects of the proposed project. Interactions with other team members should be well integrated and ongoing, not limited to attending seminars and semi-annual meetings. The role of the patient advocate should be focused on providing objective input on the research and its potential impact for individuals with or at risk for cancer.

The PRCRP is seeking to advance cancer research through development of early-career investigators. Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PIs research and career development. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. This award supports impactful research projects with an emphasis on discovery. The CDA-SO supports an independent, highly accomplished early-career investigator (referred to as a Scholar) to conduct impactful research under the guidance of an experienced cancer researcher (i.e., Career Guide). Scholars are required to participate in the unique, interactive Virtual Cancer Center (VCC) focused on fostering the next generation of cancer researchers. The overarching goal of the VCC is to develop successful, highly productive Scholars in a collaborative research and career developmental environment. The VCC will give Scholars opportunities to operate in a collegial, highly dynamic, and cutting edge research organization to lead cancer research to a new frontier. It is the intention that, through the VCC, collaborations will foster new growth to ensure the research advancements across different cancers. The VCC directorship is awarded through a separate mechanism, the Virtual Cancer Center Directors Award (VCCDA). The VCCDA calls for two established investigators (Director and Deputy Director) to provide intensive mentoring, national networking, collaborations, and a peer group for Scholars. In addition to their Career Guide, Scholars are required to interact with the VCC Director, Deputy Director, and fellow Scholars to include required attendance at in-person meeting with VCC Members annually. The intention of the Scholar Option is to support highly accomplished investigators toward the goal of leadership in cancer. The critical components of the Career Development Award: Principal Investigator: The PI must be an early-career researcher or physician-scientist within 7 years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). Time spent as a postdoctoral fellow is not excluded. Postdoctoral fellows are not eligible for this award mechanism. The PIs record of accomplishments and the proposed research will be evaluated regarding their potential for contributing to at least one of the FY24 PRCRP Topic Areas. The Scholar must be in a tenure-track position or equivalent position. The Scholar must demonstrate significant accomplishments, including first-author publications, extramural funding (beyond nominal), and show excellence in cancer research as supported by letters of recommendation. The Scholar must have independent laboratory space separate from the Career Guides laboratory or other mentors laboratory. For more information on the eligibility criteria for the Virtual Cancer Center Scholar Option, refer to Section II.C.1. Career Guide: The Scholar must designate a Career Guide. The Career Guide must be an experienced cancer researcher, as demonstrated by a strong record of funding and publications. In addition, the Career Guide must demonstrate a commitment to advancing the PIs career in cancer research and be committed to fully participating in the VCC and potentially serving on the VCCs Advisory Board as requested by VCC Leadership. Career Development Plan: A career development plan is required and should be prepared with appropriate guidance from the Career Guide. The career development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, further independence, and expertise to advance their career at the forefront of cancer research in at least one of the FY24 PRCRP Topic Areas. Milestones: The Scholar must show career milestones and pathways toward achieving the milestones. The Scholar should demonstrate clear commitment to at least one of the FY24 PRCRP Topic Areas through a career development plan designed to enhance further networking and collaboration. Impact: The applicant must articulate the potential impact the proposed work will have on cancer research and/or patient care. Impactful research will accelerate the movement of promising ideas in cancer research into clinical applications.

Dear Interested Parties: Pursuant to FAR 52.215-3 Request for Information (Oct. 1997), the United States Government, represented by The United States Agency for International Development (USAID) South Sudan Mission, is issuing the subject Request for Information (RFI) to all interested public and private entities on critical areas to support the delivery of integrated HIV care and treatment services for general and key populations including other disadvantaged populations such as people with disability and migrants. The Purposes of the care and treatment activity are: Improve equitable access to and use of quality comprehensive HIV prevention, testing, care, and treatment services for all South Sudanese. Provide quality comprehensive services for key populations at the current locations and expand as needed. Develop local partner capacity and prepare local partners to manage direct awards. This RFI is open for comments from any local Civil Society Organization (CSO), South Sudanese Organization, US, or non-US. Organization. This is an RFI, not a Request for Application (RFA). Do not submit any applications or proposals at this time; only the information requested per Attachment 1- RFI Questions for respondents and submission instructions- and all responses will be treated confidentially. Responses to this RFI may be used to help determine critical areas to support the delivery of integrated HIV care and treatment services for general and key populations, including other disadvantaged populations such as people with disability and migrants. USAID may revise the structure and concept of the activity based on the comments received, but it is not obligated to do so. All comments must be submitted electronically, with the subject of "RFI: USAID/South Sudan Care and Treatment Activity," no later than the date and time stated above. Please note: This is NOT a solicitation. This RFI is issued solely to gather information and innovative ideas for new design and planning purposes. This RFI does not constitute a Request for Applications (RFA), Request for Proposal (RFP), Notice of Funding Opportunity (NOFO), or a commitment to issue an RFA/RFP/NOFO in the future. USAID may release a full solicitation later through the US Government portal at beta.sam.gov or www.grants.gov. If you have issues accessing the link, please contact Michael Loro at [email protected] for a pdf version Thank you for your interest in sharing your views and innovative ideas with the USAID/South Sudan Mission. Sincerely, Lesley Stewart Contracting and Agreement Officer USAID/South Sudan N.B if you have issues accessing the link, please contact Michael Loro @[email protected] for a pdf version

The purpose of this RFI is to solicit feedback from industry, academia, research laboratories, government agencies, and other stakeholders on issues related to U.S domestic wind turbine blade manufacturing. EERE is specifically interested in information on current domestic blade manufacturing challenges, future domestic blade manufacturing needs, workforce, and stakeholder strategy development. This is solely a request for information and not a Funding Opportunity Announcement (FOA). EERE is not accepting applications. This is an RFI only. DOE will not pay for information provided under this RFI and no project will be supported as a result of this RFI. This RFI is not accepting applications for financial assistance or financial incentives. DOE may or may not issue a Funding Opportunity Announcement (FOA) based on consideration of the input received from this RFI. Responses to this RFI must be submitted electronically to [email protected] no later than 5:00pm (ET) on 7/30/2024. Responses must be provided as attachments to an email. To view the entire RFI document, visit the EERE Exchange Website at https://eere-exchange.energy.gov

Notice of Intent (NOI) for Funding Opportunity Announcement DE-FOA0003334 titled Offshore Wind National and Regional Research and Development. The Office of Energy Efficiency and Renewable Energy (EERE) intends to issue, on behalf of the Wind Energy Technologies Office (WETO), a Funding Opportunity Announcement (FOA) entitled Offshore Wind National and Regional Research and Development. This notice of intent (NOI) is issued so that interested parties are aware of EEREs intention to issue this FOA in the near term. All the information contained in this NOI is subject to change. EERE will not respond to questions concerning this NOI. Once the FOA has been released, EERE will provide an avenue for potential applicants to submit questions. Complete information, including the full Notice of Intent, can be found on the EERE Exchange website: https://eere-exchange.energy.gov/

Ladies/Gentlemen: The United States Agency for International Development (USAID) is seeking applications for a cooperative agreement from qualified entities to implement the Promoting Human Rights in Armenia Activity. Eligibility for this award is not restricted; both qualified U.S. and non-US organizations are eligible to apply. USAID intends to make one award to the applicant who best meets the objectives of this funding opportunity based on the merit review criteria described in this NOFO subject to a risk assessment. Eligible parties interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements and selection process. Subject to the availability of funds, the total estimated amount for this five-year activity is $10,000,000. To be eligible for the award, the applicant must provide all information as required in this NOFO and meet eligibility standards in Section C of this NOFO. This funding opportunity is posted on www.grants.gov, and may be amended. It is the responsibility of the applicant to regularly check the website to ensure they have the latest information pertaining to this notice of funding opportunity and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion process. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at [email protected] for technical assistance. USAID will not make an award to an applicant unless the applicant has complied with all applicable unique entity identifier and System for Award Management (SAM) requirements detailed in Section D. 6. (g) The registration process may take many weeks to complete. Therefore, applicants are encouraged to begin registration early in the process. Please send any questions to the points of contact identified in Section D. The deadline for questions is shown above. Responses to questions received prior to the deadline will be furnished to all potential applicants through an amendment to this notice posted to www.grants.gov. USAID currently anticipates doing only one round of Q However, interested applicants should feel free to submit additional questions to USAIDs POCs listed in Section D. If additional questions are received after amendment 1 is issued that merit answering, USAID may decide to do a second round of Q and issue a second amendment to this NOFO. Issuance of this notice of funding opportunity does not constitute an award commitment on the part of the Government nor does it commit the Government to pay for any costs incurred in preparation or submission of comments/suggestions or an application. Applications are submitted at the risk of the applicant. All preparation and submission costs are at the applicants expense.

RFI Number: 7200AA24RFI00017Issuance Date: April 22, 2024Closing Date: May 20, 2024 5:00pm EDTSubject: Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries (LMIC)To All Interested Respondents/Parties:The United States Agency for International Development (USAID) Bureau for Global Health (GH) is publishing this Request for Information (RFI) to obtain information and input that will be used to help make planning decisions. It may inform the design of future activities related to accelerating HIV vaccine research and development in low- and middle-income countries.This RFI is issued solely to collect expert inputs for information-gathering and planning purposes. This RFI does not constitute a Notice of Funding Opportunity (NOFO) or a Request for Proposals (RFP).Please also note the following:(a) responding to this Notice will not give any advantage to any organization or individual for any subsequent competition;(b) proprietary information should not be sent;(c) responses are not offers/applications and cannot be accepted by the U.S. Government to form a binding contract/award;(d) responses to this RFI are strictly voluntary, and USAID will not pay respondents for information provided in response to this RFI;(e) USAID reserves the right to, or not to, incorporate any/some/none of the comments received from RFI into subsequent solicitations or design documents and(f) applications or resumes will be discarded and should therefore not be included in your response.USAID posts its competitive business opportunities on www.sam.gov and www.grants.gov. This RFI does not restrict the Governments approach to a future solicitation or NOFO. It is the potential responders responsibility to monitor the site for the release of any further information.Questions regarding this announcement will not be accepted or answered. Not responding to this request does not preclude participation in any future solicitation, if any is issued. No basis for claims against the U.S. Government shall arise as a result of a response to this request for information or from the U.S. Governments use of such information.Submission Instructions:Only electronic submissions will be accepted. Responses to this RFI must be written in English.Respondents will only receive an electronic confirmation acknowledging receipt of their response; theywill not receive individualized feedback on any suggestions.USAID is requesting the public to submit short submissions outlining recommendations or otherinformation pertinent to the questions noted below. Responses should note the question numberaddressed and clearly relate back to the questions listed below, but responses do not need to addressevery question listed. All responses should provide sufficient detail and justification explaining why acertain recommendation is offered. Please also provide your name, title, organization, and contactinformation in the response.All submissions must adhere to the following format to ensure an efficient review: Must be written in English, size 11 Calibri font, not to exceed 20 pages total. The graphics subtextmay use a smaller font size. Submission file should be in PDF or Microsoft Word format. Submission file should be saved as ;lt;Entitys name;gt; Response to RFI 7200AA24RFI00017. The subject line for the submission email subject line must include Response to USAID/GHs RFI- Accelerating HIV Vaccine Research and Development in LMIC Must be submitted to Ms. Simone Cho at [email protected] with a copy to Mr. Elton Fortson [email protected] by the closing date and time noted at the beginning of this letter.Thank you for your interest in responding to this RFI. To learn more about partnering with USAID, pleasevisit www.work with usaid.gov.

The "DoD Multiple Sclerosis, Early Investigator Research Award" is a grant designed to support early-stage researchers in developing a Multiple Sclerosis-focused research project under the guidance of experienced mentors, with the aim of advancing their careers and contributing to the understanding and treatment of Multiple Sclerosis.

The United States Agency for International Development (USAID) Mission in Jordan issues a Request for Information (RFI) to collect data to inform the design of a new early childhood education and workforce activity. This is a Request for Information (RFI), providing information to parties interested in USAIDs support in Jordan, and seeks to collect any information and suggestions about USAIDs planned programming. Information collected is intended to contribute to the Missions activity design and development for an intended future Request for Proposal (RFP) or Request for Application (RFA).Please see the attached RFI No. 72027824RFI00004 for more information.